Monique Létourneau
Direttore/Membro del Consiglio presso Oxfam-Québec
Provenienza dei contatti di primo grado di Monique Létourneau
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.
18
| Private Company | Pharmaceuticals: Major | 18 |
Oxfam-Québec
 Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Monique Létourneau tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
Pioneer Companies, Inc.
 Pioneer Companies, Inc. Chemicals: SpecialtyProcess Industries Pioneer Cos., Inc. manufactures and distributes chemical and related products. Its products include chlorine and caustic soda. The company was founded in 1988 and is headquartered in Houston, TX. | Chemicals: Specialty | Corporate Officer/Principal | |
Pioneer Americas, Inc.
 Pioneer Americas, Inc. Chemicals: SpecialtyProcess Industries Part of Olin Corp., Pioneer Americas, Inc. is a company that produces chlorine, caustic soda, and other related products. The company is based in Houston, TX. Pioneer Americas was acquired by GEV Corp. on April 20, 1995. | Chemicals: Specialty | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Masters Business Admin | |
| SANOFI INDIA LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Chief Executive Officer | |
Apicap SAS
 Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris. | Investment Managers | Private Equity Investor | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Montréal | College/University | Director/Board Member Undergraduate Degree Doctorate Degree | |
PrimeBioTech
 PrimeBioTech Medical DistributorsDistribution Services PrimeBioTech develops therapeutic products based on gene therapy technologies. The private company is based in Paris, France. | Medical Distributors | President | |
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member | |
| GENFIT | Pharmaceuticals: Major | Director/Board Member | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
| University of Sherbrooke | College/University | Graduate Degree Undergraduate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
| ESSEC Business School | College/University | Undergraduate Degree | |
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| ALTUR INVESTISSEMENT | Investment Managers | Chief Executive Officer | |
W SAS
 W SAS Internet Software/ServicesTechnology Services W SAS owns and operates an online portal for e-greetings. It offers a collection of e-greetings for festivals, wishes, entertainment, sentiments, cultures, and other situations. The company was founded by Dany Rafik Smati and is headquartered in Puteaux, France. | Internet Software/Services | Director/Board Member | |
| NANOBIOTIX | Medical Specialties | Corporate Officer/Principal | |
BIOBank SA
 BIOBank SA Medical/Nursing ServicesHealth Services BIObank SA engages in human tissue development. It prepares, preserves, distributes, and transfers tissues for therapeutic human use. The company was founded by Philippe Chaix, Pierre Lory, and William Gazi on November 4, 1999 and is headquartered in Lieusaint, France. | Medical/Nursing Services | Director/Board Member | |
| ACROPOLIS TELECOM | Specialty Telecommunications | Director/Board Member | |
| CANSO Chemicals Ltd. | Corporate Secretary | ||
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| Renaissance Corporate SAS | Investment Managers | President | |
Solem SAS
 Solem SAS Industrial MachineryProducer Manufacturing Solem SAS manufactures hardware materials. It specializes in hoisting and handling equipment. The company was founded on July 21, 1987 and is headquartered in Epinay-sur-Seine, France. | Industrial Machinery | Director/Board Member | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Chief Executive Officer | |
| The BayHelix Group | Corporate Officer/Principal | ||
| Pets Health Pty Ltd. | Director/Board Member | ||
Turenne Holding
 Turenne Holding Miscellaneous Commercial ServicesCommercial Services Turenne Holding provides business and management advisory services. The private company is based in Paris, France. | Miscellaneous Commercial Services | Chairman | |
| ASCLETIS PHARMA INC. | Biotechnology | Chief Executive Officer | |
| Rfas 3 | Chairman | ||
Rfas 4
 Rfas 4 Financial ConglomeratesFinance Rfas 4 functions as an investment holding French company. The private company is based in Paris, France. and has subsidiaries in France. | Financial Conglomerates | Chairman | |
| Ascletis BioScience Co., Ltd. | Chief Executive Officer | ||
| Ascletis Pharma China Co., Ltd. | Director/Board Member | ||
| Ascletis Xinnuo Medicine Co., Ltd | Chief Executive Officer | ||
| Soundridge Pharmaceuticals (Hong Kong) Co., Ltd. | Director/Board Member | ||
| Gannex LLC | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Francia | 24 |
| Stati Uniti | 10 |
| Canada | 9 |
| Cina | 7 |
| Svizzera | 2 |
Settori
| Health Technology | 18 |
| Consumer Services | 8 |
| Finance | 7 |
| Process Industries | 4 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 91 |
| Chairman | 38 |
| Corporate Officer/Principal | 34 |
| President | 33 |
| Chief Executive Officer | 28 |
Contatti più connessi
| Insiders | |
|---|---|
| Max E. Link | 28 |
| Chandrakant Panchal | 22 |
| Jinzi Wu | 20 |
| François Lombard | 19 |
| Philippe Calais | 18 |
| Joseph J. Krivulka | 17 |
| Stephen G. Sudovar | 12 |
| Rita-Rose Gagné | 9 |
| Richard la Rue | 9 |
| Frédéric Porte | 9 |
| Philip S. Tabbiner | 9 |
| Geneviève Foster | 9 |
| Bernard Coupal | 8 |
| Hans J. Mäder | 8 |
| Christine Beaubien | 8 |
- Borsa valori
- Insiders
- Monique Létourneau
- Connessioni Società
